New Delhi: Health authorities in Delhi on Sunday released an advisory to prepare for potential health challenges linked to Human Metapneumovirus (HMPV) and other respiratory viruses amid growing cases in China.
The advisory follows reports of a rise in respiratory illnesses in China. However, updates from the IDSP, National Centre for Disease Control (NCDC), and the World Health Organization (WHO) indicate no significant surge in respiratory illnesses in India as of January 2, 2025, officials said.
The advisory from the Delhi government came days after the Union Health Ministry said that there was no need to be alarmed and asked citizens to take regular precautions, like in the case of respiratory diseases.
Medical facilities were directed to maintain detailed records of Severe Acute Respiratory Infection (SARI) cases and lab-confirmed influenza cases to ensure accurate monitoring.
They were further advised to stock up on medicines like paracetamol, antihistamines, bronchodilators, and cough syrups, along with oxygen for treating mild cases.
WHAT IS HMPV?
The virus primarily targets the respiratory system, causing mild to severe infections. The transmission of the disease occurs through respiratory droplets and contact with contaminated surfaces.
Even though they belong to different viral families, many have likened HMPV to Covid-19 virus as their symptoms are strikingly similar when it comes to its transmission and symptoms as well.
Like COVID, HMPV also targets the respiratory system. Like COVID, HMPV also affects immunocompromised individuals, children and adults.
HMPV typically causes symptoms resembling a common cold, such as cough, wheezing, runny nose, or sore throat.
However, in young children, the elderly, and people with weakened immune systems, the virus can lead to severe respiratory complications, requiring prompt medical attention.
(Courtesy India Today)
